Background We estimated vaccine effectiveness (VE) of the COVID-19 monovalent XBB.1.5 vaccine recommended in Spain in October 2023 for ≥60-year-olds against medically-attended COVID-19 and COVID-19 hospitalization, during winter and summer epidemic waves.
Rojas‐Benedicto et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: